Sam Altman shelved OpenAI's public listing citing AI safety, while rival Anthropic targets an October Nasdaq debut at a record $2 trillion valuation led by Goldman Sachs and JPMorgan.
- Sam Altman called a 2026 OpenAI IPO "ill-advised," citing AI safety concerns, pushing any listing to 2027 at the earliest.
- Anthropic filed a confidential S-1 with the SEC in June 2026, targeting an October Nasdaq debut at a $2 trillion valuation.
- Goldman Sachs, JPMorgan, and Morgan Stanley are leading Anthropic's offering, expected to raise more than $60 billion.
OpenAI Steps Back From a Historic Listing
OpenAI chief executive Sam Altman confirmed on September 12, 2026, that the San Francisco-based artificial intelligence company will not pursue a public offering this year, calling the current moment "ill-advised" for a market debut. Altman cited unresolved questions about AI safety and alignment as the primary rationale, arguing that OpenAI and its frontier-model peers require additional time to address extinction-level capability risks before seeking public-market capital. The company, which had been in preliminary discussions for a potentially trillion-dollar IPO, now targets 2027 at the earliest for any listing.Why Did Sam Altman Call an IPO Ill-Advised Now?
Altman cited the pace of frontier model development as the central reason for shelving the offering. OpenAI has discussed internally pausing certain training runs as its models reach new capability thresholds - a step designed to allow safety and alignment research to catch up with engineering advances. Altman argued that subjecting the company to the quarterly earnings scrutiny and capital-return pressures of a public listing while navigating those decisions would create misaligned incentives at a critical development juncture. The delay removes what would have been one of the largest technology listings in U.S. history from the 2026 calendar.
Anthropic Accelerates Toward a Record Nasdaq Debut
While OpenAI retreats, Anthropic filed a confidential draft S-1 with the Securities and Exchange Commission on June 1, 2026, setting the stage for an October listing on the Nasdaq. The company selected Goldman Sachs (GS), JPMorgan (JPM), and Morgan Stanley (MS) as lead underwriters for an offering expected to raise more than $60 billion. Anthropic most recently carried a private valuation of $965 billion following its May 2026 Series H-1 funding round; the public debut targets a $2 trillion valuation, which would surpass SpaceX's $1.77 trillion listing in June 2026 as the largest IPO in U.S. history.
How to Invest in AI Through Anthropic's October Offering
Retail access to Anthropic's IPO will depend on brokerage allocation, which in deals of this scale is predominantly directed to institutional investors in the initial tranche. Anthropic's annualized revenue run rate exceeded $65 billion by the end of July 2026, up from approximately $47 billion in May, underpinning the $2 trillion target multiple. Amazon (AMZN) and Alphabet (GOOG) are existing strategic investors in Anthropic through their respective cloud infrastructure partnerships, while Microsoft (MSFT) holds its major AI stake via a multi-year deal with OpenAI. Investors tracking the broader ai stocks theme are watching the Anthropic listing as a potential valuation benchmark for the sector.
Strategic Divergence With Market Consequences
The parallel announcements reveal a deepening strategic split within the frontier AI industry. OpenAI, under pressure to demonstrate safety credentials, is accepting a slower path to liquidity for employees and early investors. Anthropic - whose founder and CEO Dario Amodei departed OpenAI in 2021 partly over safety disagreements - is moving in the opposite direction, treating the public markets as validation of both its commercial traction and its safety-first model governance.
The contrast gives institutional investors a live referendum on which AI development philosophy the market will reward at scale. OpenAI's withdrawal also clears the autumn IPO calendar of its most direct competitor for institutional allocations, potentially strengthening demand for Anthropic's book-building in the roadshow period.
Outlook
Anthropic's October roadshow will test whether public-market investors assign a $2 trillion price to an AI company reporting $65 billion in annualized revenue but no disclosed path to profitability. OpenAI's delay shifts pressure onto Anthropic to set the sector's valuation floor. The Nasdaq QQQ (QQQ) technology index would automatically include Anthropic upon listing if the company meets index eligibility thresholds, extending passive exposure to millions of retail portfolios. For OpenAI, the timeline extension moves the conversation squarely toward 2027 milestones - on both AI safety and revenue scale - before any public offering can credibly resume.





